发明名称 |
PAK MODULATORS |
摘要 |
The present invention provides methods for treating fragile X syndrome and/or other neurodevelopmental disorders by administering p21-activated kinase (PAK) modulators to a patient suffering from, susceptible to, and/or exhibiting one or more symptoms of FXS and/or other neurodevelopmental disorders. The present invention provides PAK modulators and pharmaceutical compositions comprising PAK modulators. The present invention further provides methods for identifying and/or characterizing PAK modulators.
|
申请公布号 |
US2010247552(A1) |
申请公布日期 |
2010.09.30 |
申请号 |
US20070514288 |
申请日期 |
2007.11.09 |
申请人 |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
发明人 |
TONEGAWA SUSUMU;HAYASHI MANSUO L.;DOLAN BRIDGET |
分类号 |
A61K39/395;A01K67/027;A61K31/122;A61K31/415;A61K38/17;A61K48/00;A61P15/00;A61P25/00;C12Q1/48;G01N33/00;G01N33/573 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|